News
Ultomiris, which is used to treat certain rare diseases, can cause side effects. Learn about its more common, mild, and serious side effects and how to manage them.
Ultomiris (ravulizumab-cwvz) is a brand-name drug prescribed for certain inflammatory diseases. Ultomiris comes as a solution for intravenous (IV) infusion. It’s given by a healthcare ...
Ultomiris (ravulizumab-cwvz) is a brand-name infusion prescribed for myasthenia gravis. This article covers topics such as side effects, dosage, and how Ultomiris works.
Ultomiris (ravulizumab-cwvz) is a prescription drug that’s used to treat myasthenia gravis and other conditions. Ultomiris’s cost may depend on factors such as your dosage and whether you have ...
Ultomiris is part of a Risk Evaluation and Mitigation Strategy (REMS) program. A REMS program is required for certain medicines, such as Ultomiris, that can have serious side effects.
Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved ULTOMIRIS ® for the treatment of atypical hemolytic uremic syndrome to inhibit complement ...
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "ULTOMIRIS Market Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides ...
AstraZeneca has been successful at rolling out its long-acting complement C5 inhibitor Ultomiris in the uses approved for its predecessor Soliris – until now, that is. The drugmaker confirmed ...
Soliris and Ultomiris control symptoms, but they don't cure PNH. You'll need to take medicine for the rest of your life, or until your disease goes into remission. ...
CHMP recommends AstraZeneca's (AZN) Ultomiris for the treatment of patients with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 antibody positive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results